RC010 Inhalation Powder
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Nanjing Reju Therapeutics Co., Ltd
Overview
RC010 Inhalation Powder is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
RC010 Inhalation Powder clinical trials
Explore related
Medical disclaimer. This page summarizes research about RC010 Inhalation Powder for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.